{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-048030","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.834241+00:00","generated_at":"2026-06-01T07:26:13.125165+00:00","sec_items":["3.01","5.02"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"BiomX receives NYSE American delisting notice for equity deficiency; interim CFO departs","bullets":["Stockholders' capital deficiency of $9.5M as of March 31, 2024; losses in five recent fiscal years.","Plan to regain compliance due June 22, 2024; final compliance deadline November 23, 2025.","Expects to reclassify $32.4M to equity via Series X Preferred conversion at July 2024 shareholder meeting.","Common stock to trade with '.BC' designation during cure period.","Interim CFO Avraham Gabay steps down May 31, 2024; CFO Marina Wolfson returns from maternity leave."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-048030","json":"https://secwatch.observer/filing/0001213900-24-048030.json","markdown":"https://secwatch.observer/filing/0001213900-24-048030.md","text":"https://secwatch.observer/filing/0001213900-24-048030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/ea020712501-8k_biomxinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:26:13.125165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e2f920599","claim":"Marina Wolfson was appointed as Chief Financial Officer at BiomX Inc..","evidence_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","confidence":0.85},{"claim_id":"70629b8d84","claim":"Avraham Gabay departed as Interim Chief Financial Officer at BiomX Inc..","evidence_excerpt":"Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001193125-26-237207","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-05-22T21:28:16+00:00","headline":"Tempest Therapeutics warned by Nasdaq for low equity and board independence; two directors resign","event_type":"regulatory","sec_items":["3.01","5.02"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: executive_change","same SEC item: 3.01, 5.02","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-237207","json":"https://secwatch.observer/filing/0001193125-26-237207.json","markdown":"https://secwatch.observer/filing/0001193125-26-237207.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/d131489d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"resignations of Mr. Michael Raab and Ms. Christine Pellizzari from the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm"}},{"accession":"0001499275-26-000014","ticker":"GROO","company_name":"GROOVY COMPANY, INC.","filed_at":"2026-05-28T19:28:28+00:00","headline":"Groovy dismisses auditor after SEC suspension, reduces authorized common 99.5%, two officers depart","event_type":"regulatory","sec_items":["4.01","4.02","5.03","5.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001499275-26-000014","json":"https://secwatch.observer/filing/0001499275-26-000014.json","markdown":"https://secwatch.observer/filing/0001499275-26-000014.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000014/0001499275-26-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000014/groo-20250813_8ka.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"Effective May 1, 2026, Jeffrey D. Turner ceased to serve as the Company’s Chief Legal Officer.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000014/0001499275-26-000014-index.htm"}},{"accession":"0001193125-26-251758","ticker":"OCFC","company_name":"OCEANFIRST FINANCIAL CORP","filed_at":"2026-06-01T21:19:28+00:00","headline":"OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus","event_type":"m_and_a","sec_items":["1.01","3.02","2.01","2.03","3.03","5.02","5.03","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251758","json":"https://secwatch.observer/filing/0001193125-26-251758.json","markdown":"https://secwatch.observer/filing/0001193125-26-251758.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/d145829d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"Todd Schell, designated by Warburg, was appointed to serve as a director of OceanFirst","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm"}},{"accession":"0001750155-26-000080","ticker":"CWBHF","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2026-06-01T21:13:23+00:00","headline":"Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment","event_type":"other_material","sec_items":["5.02","5.07","8.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001750155-26-000080","json":"https://secwatch.observer/filing/0001750155-26-000080.json","markdown":"https://secwatch.observer/filing/0001750155-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/cweb-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm"}},{"accession":"0001193125-26-251709","ticker":"CRVL","company_name":"CORVEL CORP","filed_at":"2026-06-01T21:05:42+00:00","headline":"CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251709","json":"https://secwatch.observer/filing/0001193125-26-251709.json","markdown":"https://secwatch.observer/filing/0001193125-26-251709.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/0001193125-26-251709-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/d24231d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/0001193125-26-251709-index.htm"}},{"accession":"0001671933-26-000063","ticker":"TTD","company_name":"Trade Desk, Inc.","filed_at":"2026-06-01T20:35:28+00:00","headline":"The Trade Desk appoints Nate Olmstead as CFO effective July 9, 2026; interim CFO Davis resumes CAO role","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001671933-26-000063","json":"https://secwatch.observer/filing/0001671933-26-000063.json","markdown":"https://secwatch.observer/filing/0001671933-26-000063.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671933/000167193326000063/0001671933-26-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671933/000167193326000063/ttd-20260601.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1671933/000167193326000063/0001671933-26-000063-index.htm"}},{"accession":"0000105770-26-000080","ticker":"WST","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2026-06-01T20:32:30+00:00","headline":"West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-26-000080","json":"https://secwatch.observer/filing/0000105770-26-000080.json","markdown":"https://secwatch.observer/filing/0000105770-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm"}},{"accession":"0001193125-26-251522","ticker":"VRRM","company_name":"VERRA MOBILITY Corp","filed_at":"2026-06-01T20:29:13+00:00","headline":"Verra Mobility CEO David Roberts steps down amid cost realignment; interim CEO Keyser appointed","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251522","json":"https://secwatch.observer/filing/0001193125-26-251522.json","markdown":"https://secwatch.observer/filing/0001193125-26-251522.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682745/000119312526251522/0001193125-26-251522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682745/000119312526251522/d39754d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"following Ms. Marina Wolfson’s return from maternity leave","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024048030/0001213900-24-048030-index.htm","comparable_excerpt":"On June 1, 2026, Verra Mobility Corporation (the “Company”) announced that the Board of Directors of the Company (the “Board”) approved the appointment of Jonathan Keyser as the Interim President and Chief Executive Officer of the Company, effective May 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1682745/000119312526251522/0001193125-26-251522-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}